The information contained in the site is intended for US healthcare professionals only. By selecting “Okay” below, you verify that you are a licensed US healthcare professional.
NoReview the Global RING Study which determined the reproducibility and comparability of CLDN18 testing in gastric cancer.
Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.
Access a self-guided CLDN18.2 educational program.
Visit the eLearning Site
Explore the results of two phase 3 clinical trials focused on the analytical and clinical performance of the VENTANA CLDN18 (43-14A) RxDx Assay.